Lourdes G. S.
- Country
- Spain
- Department
- Oncology
Research Overview
- A Pharmacokinetic Comparison of JPB898 and Nivolumab in Patients with Resected Stage IIB, IIC, or III Melanoma in the Adjuvant Setting
- Phase 3 Randomized Study of Perioperative Dostarlimab vs. Standard of Care in Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- Efficacy and Safety Evaluation of GSK5764227 Monotherapy and Combination Therapy in Advanced Unresectable or Metastatic Gastrointestinal Neoplasms
Data & Insights
Has run more than one trial at 41 of 155 partner sites.
Specializations
Oncology Focus
The investigator specializes in treating advanced forms of melanoma and colon cancer, with particular emphasis on managing cases that require innovative therapeutic approaches.
- Advanced Melanoma Management
- Stage III and IV Melanoma Treatment
- Resectable Colon Cancer
Working with both early-stage and advanced cancer patients, focusing on personalized treatment strategies.
Therapeutic Expertise
Demonstrates expertise in immunotherapy applications, particularly in the context of combination therapy approaches for cancer treatment.
- Novel Agent Implementation
- Immunotherapy Combinations
- Perioperative Treatment
Specializes in treatment protocols for patients who have not responded to conventional therapies.
Clinical Focus Areas
Concentrates on treating specific molecular subtypes of cancer, including dMMR/MSI-H tumors and implementing targeted therapeutic strategies.
- Biomarker-Driven Treatment
- Response Evaluation
- Surgical Oncology Integration
Expertise in evaluating treatment responses using standardized criteria for solid tumors.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.